BioVox

With a local focus and global reach, the news platform BioVox shares insights into the Benelux life sciences ecosystem with readers across the world. BioVox is an independent publisher, providing its community with quality content and first-row access to interesting breakthroughs and trends in biotech, medtech, agtech, pharma, and more. We shine a spotlight on the latest news and innovations from both our partners and community.

BioVox

With a local focus and global reach, the news platform BioVox shares insights into the Benelux life sciences ecosystem with readers across the world. BioVox is an independent publisher, providing its community with quality content and first-row access to interesting breakthroughs and trends in biotech, medtech, agtech, pharma, and more. We shine a spotlight on the latest news and innovations from both our partners and community.

December 6, 2016

IPO of Tigenix finally a fact!

for BioVox

TiGenix will issue 55 million new shares at the current share price, accounting for a capital injection of 50 million euros.

December 6, 2016

Animal venom: a pharmacological goldmine

for BioVox

December 6, 2016

Music or neuroscience? Balthazar’s violinist chose music (at least for now)

for BioVox

For Patricia Vanneste, violinist with the popular rock group Balthazar, it wasn’t a choice she made lightly. Patricia has played the violin since she was five. [...]

December 5, 2016

Watson is here to cure cancer

for BioVox

The cooperation between Pfizer and IBM concerning Watson, an artificial intelligence system, was announced on the Forbes Healthcare Summit following a pilot project during the past year and a half.

November 30, 2016

Ablynx quickly delivers on Novo Nordisk collaboration

for BioVox

November 29, 2016

Ontoforce wins European Digital Health prize

for BioVox

November 28, 2016

GiGa gets one step closer to curing atopic dermatitis

for BioVox

November 25, 2016

New Familial Mediterranean Fever Diagnostic Tool

for BioVox

November 24, 2016

Finnish start-up brings cancer care in digital format

for BioVox

November 23, 2016

Celyad about to start second cancer immunotherapy clinical trial

for BioVox

November 17, 2016

Biocartis’ mini-lab soon available on US market

for BioVox

November 16, 2016

First human treated with CRISPR

for BioVox

November 16, 2016

Multiplicom: a strong focus on DNA analysis

for BioVox

November 15, 2016

Second and third lives for known cancer drugs

for BioVox

November 15, 2016

Life sciences high on the UGent priority list

for BioVox